Autologous cell therapy

BIOLOGICAL2 trials

Sponsors

BioCardia, Inc., Dr. Grant M. Pagdin

Conditions

Heart Failure, SystolicOsteoarthritis

Phase 2

The Combined Use of PRP with Lipoaspirate And/or Bone Marrow Aspirate in Osteoarthritis

RecruitingNCT03984461

Dr. Grant M. PagdinOsteoarthritis

Start: 2020-09-01End: 2027-12-31Target: 240Updated: 2024-11-15

Phase 3

CardiAMP™ Cell Therapy for Heart Failure Trial

CompletedNCT02438306

BioCardia, Inc.Heart Failure, Systolic

Start: 2016-12-31End: 2025-06-30Updated: 2025-09-19

Related Papers

The CardiAMP Cell Therapy for Heart Failure trial

Texas Heart Institute Journal2023-10-232 citations

Point of care, bone marrow mononuclear cell therapy in ischemic heart failure patients personalized for cell potency: 12-month feasibility results from CardiAMP heart failure roll-in cohort.

2020-10-2014 citations